SLC4A1 (Band 3 anion transport protein) variants and mutations
SLC4A1 (also known as Band 3 anion transport protein) is a human protein-coding gene encoding a band 3 anion transport protein. In red blood cells it exchanges chloride and bicarbonate to support carbon-dioxide transport, while in renal intercalated cells it is required for acid-base regulation. Pathogenic variants can cause hereditary spherocytosis or distal renal tubular acidosis depending on the affected function. This analysis covers 1,303 SLC4A1 variants and mutations. Of these, 73% have computational variant effect predictions. Disease context includes hereditary spherocytosis type 4, autosomal dominant distal renal tubular acidosis, and renal tubular acidosis, distal, 4, with hemolytic anemia. Example SLC4A1 variants include E2K, E2Q, and Q5=.
Variant analysis overview
- Gene: SLC4A1
- Protein: Band 3 anion transport protein
- UniProt accession: P02730
- Organism: Homo sapiens
- Variants analyzed: 1303
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,083 unspecified-consequence records; 1 stop retained variant; 101 missense variants; 107 synonymous variants; 2 frameshift variants; 1 in-frame deletions; 1 in-frame insertions; 4 splice-region variants; 3 substitution
- Prediction scores: 952 variants have prediction scores (73% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: hereditary spherocytosis type 4, autosomal dominant distal renal tubular acidosis, renal tubular acidosis, distal, 4, with hemolytic anemia, southeast Asian ovalocytosis, hereditary spherocytosis, cryohydrocytosis, Hereditary cryohydrocytosis with normal stomatin, non-autoimmune hemolytic anemia, distal renal tubular acidosis, Distal renal tubular acidosis with anemia, hematologic disorder, Congenital hemolytic anemia.
Protein structure and variant hotspots
- Protein features: 12 transmembrane segments; 9 post-translational modification sites.
- Structural context: 358 variants have structural context.
- PTM context: 8 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SLC4A1 variants
Examples include E2K, E2Q, Q5=, Q5R, E9G, E9K, D10V, M11I. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- E2K (p.Glu2Lys), rs777378002, NCI-TCGA Cosmic COSV9929, cosmic curated COSV99293, ExAC rs777378002, REVEL 0.21, CADD 14.90, Variant assessed as somatic; moderate impact.
- E2Q (p.Glu2Gln), ExAC rs777378002, gnomAD rs777378002, REVEL 0.24, CADD 13.90
- Q5=, NCI-TCGA Cosmic COSV5225, Variant assessed as somatic; low impact.
- Q5R (p.Gln5Arg), NCI-TCGA Cosmic COSV5226, cosmic curated COSV52262, Ensembl rs2047458921, Variant assessed as somatic; moderate impact.
- E9G (p.Glu9Gly), ExAC rs781547181, TOPMed rs781547181, gnomAD rs781547181, REVEL 0.28, CADD 23.00
- E9K (p.Glu9Lys), Ensembl rs867756325, REVEL 0.27, CADD 23.20
- D10V (p.Asp10Val), TOPMed rs1199756918, gnomAD rs1199756918, REVEL 0.13, CADD 16.20, Uncertain significance, Hereditary spherocytosis type 4; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- M11I (p.Met11Ile), rs764087255, ClinGen CA8600746, ClinVar RCV001959398, ExAC rs764087255, REVEL 0.14, CADD 7.57, Uncertain significance, not provided
- M11L (p.Met11Leu), ExAC rs751603156, REVEL 0.07, CADD 0.65
- M11R (p.Met11Arg), rs1053490380, ClinGen CA290936873, ClinVar RCV001211036, TOPMed rs1053490380, REVEL 0.10, CADD 0.02, Likely benign, not provided
- M11T (p.Met11Thr), cosmic curated COSV52261, TOPMed rs1053490380, gnomAD rs1053490380, REVEL 0.08, CADD 0.00, Uncertain significance
- M12I (p.Met12Ile), TOPMed rs1279075319, gnomAD rs1279075319, REVEL 0.17, CADD 17.30
- M12R (p.Met12Arg), TOPMed rs1340195567, gnomAD rs1340195567, REVEL 0.08, CADD 15.10
- M12T (p.Met12Thr), TOPMed rs1340195567, gnomAD rs1340195567, REVEL 0.05, CADD 10.30
- E13* (p.Glu13Ter), rs2144625139, ClinGen CA399798515, NCI-TCGA Cosmic COSV5226, cosmic curated COSV52260, Pathogenic
- E13D (p.Glu13Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E14D (p.Glu14Asp), NCI-TCGA Cosmic COSV5225, cosmic curated COSV52258, Variant assessed as somatic; moderate impact.
- E14K (p.Glu14Lys), ExAC rs763516149, TOPMed rs763516149, gnomAD rs763516149, REVEL 0.11, CADD 1.71
- L16M (p.Leu16Met), NCI-TCGA Cosmic COSV5225, NCI-TCGA Cosmic COSV9929, cosmic curated COSV99293, Variant assessed as somatic; moderate impact.
- E17K (p.Glu17Lys), gnomAD rs1334113918, REVEL 0.21, CADD 13.20
- E19K (p.Glu19Lys), rs55926998, ClinGen CA8600744, ClinVar RCV001872999, 1000Genomes rs55926998, REVEL 0.07, CADD 8.50, Uncertain significance, not provided
- E20K (p.Glu20Lys), NCI-TCGA Cosmic COSV5225, cosmic curated COSV52258, Variant assessed as somatic; moderate impact.
- Y21C (p.Tyr21Cys), cosmic curated COSV52260, TOPMed rs1220892947, gnomAD rs1220892947, REVEL 0.32, CADD 23.10
- P24S (p.Pro24Ser), NCI-TCGA Cosmic COSV9929, cosmic curated COSV99293, Variant assessed as somatic; moderate impact.
- P24T (p.Pro24Thr), NCI-TCGA Cosmic COSV9929, Variant assessed as somatic; moderate impact.
- D25A (p.Asp25Ala), gnomAD rs1465425529, REVEL 0.08, CADD 0.63
- D25V (p.Asp25Val), gnomAD rs1465425529, REVEL 0.11, CADD 0.75
- I26V (p.Ile26Val), ExAC rs772984725, TOPMed rs772984725, gnomAD rs772984725, REVEL 0.03, CADD 0.00
- P27H (p.Pro27His), UniProt VAR 058035
- P27L (p.Pro27Leu), cosmic curated COSV52259, TOPMed rs2047456542
- P27R (p.Pro27Arg), NCI-TCGA Cosmic COSV5225, Variant assessed as somatic; moderate impact.
- E28K (p.Glu28Lys), rs55637644, ClinGen CA8600739, ClinVar RCV002597087, ClinVar RCV005008646, REVEL 0.11, CADD 0.01, Conflicting interpretations, not provided; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- S29A (p.Ser29Ala), TOPMed rs1210511088, gnomAD rs1210511088, REVEL 0.07, CADD 0.00, Conflicting interpretations, Hereditary spherocytosis type 4; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- S29F (p.Ser29Phe), TOPMed rs879030630, gnomAD rs879030630, REVEL 0.10, CADD 0.45
- Q30H (p.Gln30His), NCI-TCGA TCGA novel, REVEL 0.13, CADD 2.06, Variant assessed as somatic; moderate impact.
- M31I (p.Met31Ile), TOPMed rs879106259, gnomAD rs879106259, REVEL 0.09, CADD 5.44, Uncertain significance, Hereditary spherocytosis type 4; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- M31K (p.Met31Lys), 1000Genomes rs55773290, ExAC rs55773290, TOPMed rs55773290, gnomAD rs55773290, REVEL 0.14, CADD 2.69, Uncertain significance, not provided
- M31L (p.Met31Leu), TOPMed rs990089479, gnomAD rs990089479, REVEL 0.09, CADD 0.05
- M31R (p.Met31Arg), 1000Genomes rs55773290, ExAC rs55773290, TOPMed rs55773290, gnomAD rs55773290, REVEL 0.14, CADD 7.28, Likely benign, not provided
- M31T (p.Met31Thr), rs55773290, ClinGen CA8600736, ClinVar RCV000903910, ClinVar RCV001122075, REVEL 0.11, CADD 2.23, Benign/Likely benign, Autosomal dominant distal renal tubular acidosis; Hemolytic anemia; not provided
- E32D (p.Glu32Asp), NCI-TCGA Cosmic COSV5225, cosmic curated COSV52259, Variant assessed as somatic; moderate impact.
- P34L (p.Pro34Leu), rs56312419, 1000Genomes rs56312419, ESP rs56312419, ExAC rs56312419, REVEL 0.10, CADD 13.70, Variant assessed as somatic; moderate impact.
- A35T (p.Ala35Thr), TOPMed rs1271763556, gnomAD rs1271763556, REVEL 0.06, CADD 4.96
- A36T (p.Ala36Thr), NCI-TCGA TCGA novel, REVEL 0.21, CADD 23.30, Variant assessed as somatic; moderate impact.
- D38A (p.Asp38Ala), rs5035, ClinGen CA8600706, cosmic curated COSV52259, ClinVar RCV000242676, REVEL 0.09, CADD 1.16, Benign, not specified; not provided; Hereditary spherocytosis type 4
- D38N (p.Asp38Asn), ESP rs149644876, ExAC rs149644876, TOPMed rs149644876, gnomAD rs149644876, REVEL 0.09, CADD 0.69, Uncertain significance, Hereditary spherocytosis type 4; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- D38V (p.Asp38Val), 1000Genomes rs5035, ESP rs5035, ExAC rs5035, TOPMed rs5035, REVEL 0.12, CADD 1.99, Benign
- T39I (p.Thr39Ile), TOPMed rs1490869125, gnomAD rs1490869125, REVEL 0.12, CADD 14.10
- E40K (p.Glu40Lys), rs45562031, ClinGen CA127375, ClinVar RCV000019333, ClinVar RCV000298897, REVEL 0.21, CADD 13.30, Conflicting interpretations, Distal renal tubular acidosis; Cryohydrocytosis; not provided
- A41P (p.Ala41Pro), gnomAD rs1355116360, REVEL 0.15, CADD 6.90
- A41S (p.Ala41Ser), gnomAD rs1355116360, REVEL 0.12, CADD 2.15
- T44K (p.Thr44Lys), ExAC rs756472075, TOPMed rs756472075, gnomAD rs756472075, REVEL 0.13, CADD 15.90
- D45E (p.Asp45Glu), rs34700496, UniProt VAR 036693, Ensembl rs34700496
- Y46S (p.Tyr46Ser), Ensembl rs2144622838
- H47N (p.His47Asn), TOPMed rs895769487, REVEL 0.09, CADD 0.07, Uncertain significance, not provided
- T48I (p.Thr48Ile), gnomAD rs2047445262, REVEL 0.05, CADD 9.88, Uncertain significance, Hereditary spherocytosis type 4; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- T48S (p.Thr48Ser), gnomAD rs2047445262, REVEL 0.08, CADD 6.19, Uncertain significance
- H51P (p.His51Pro), Ensembl rs2144622794
- H51Q (p.His51Gln), NCI-TCGA Cosmic COSV5226, cosmic curated COSV52261, REVEL 0.12, CADD 0.00, Variant assessed as somatic; moderate impact.
- P52L (p.Pro52Leu), ExAC rs751216460, TOPMed rs751216460, gnomAD rs751216460, REVEL 0.06, CADD 4.86
- P52Q (p.Pro52Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P52T (p.Pro52Thr), NCI-TCGA Cosmic COSV9929, cosmic curated COSV99293, Variant assessed as somatic; moderate impact.
- G53C (p.Gly53Cys), ExAC rs762611304, gnomAD rs762611304, REVEL 0.20, CADD 21.60
- G53D (p.Gly53Asp), TOPMed rs1343209793, gnomAD rs1343209793, REVEL 0.04, CADD 7.89
- T54I (p.Thr54Ile), Ensembl rs2144622739, Uncertain significance, Hereditary spherocytosis type 4; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- K56E (p.Lys56Glu), rs5036, ClinGen CA210832, cosmic curated COSV52259, ClinVar RCV000019328, REVEL 0.08, CADD 5.54, Benign/Likely benign, not provided; not specified; Hereditary spherocytosis type 4
- K56R (p.Lys56Arg), 1000Genomes rs542327721, ExAC rs542327721, gnomAD rs542327721, REVEL 0.15, CADD 23.60, Uncertain significance, not provided
- V57A (p.Val57Ala), Ensembl rs2047437768, REVEL 0.07, CADD 18.30
- V57I (p.Val57Ile), ExAC rs764706733, TOPMed rs764706733, gnomAD rs764706733, REVEL 0.10, CADD 17.30
- V57L (p.Val57Leu), ExAC rs764706733, TOPMed rs764706733, gnomAD rs764706733, REVEL 0.11, CADD 22.40
- Y58C (p.Tyr58Cys), rs368863744, ClinGen CA8600679, ClinVar RCV000305664, ClinVar RCV000339556, REVEL 0.36, CADD 20.80, Conflicting interpretations, not provided; Hereditary spherocytosis type 4; Autosomal dominant distal renal t
- V59E (p.Val59Glu), rs766170301, ClinGen CA8600678, ClinVar RCV003322343, ExAC rs766170301, REVEL 0.89, CADD 28.20, Uncertain significance, not specified
- V59L (p.Val59Leu), TOPMed rs2047437641, REVEL 0.46, CADD 23.10
- V59M (p.Val59Met), TOPMed rs2047437641, REVEL 0.53, CADD 26.50
- E60A (p.Glu60Ala), ExAC rs760664657, gnomAD rs760664657, REVEL 0.76, CADD 33.00
- E60D (p.Glu60Asp), ESP rs369101481, ExAC rs369101481, gnomAD rs369101481, REVEL 0.59, CADD 25.20
- Q62* (p.Gln62Ter), rs2509971425, ClinGen CA399796603, ClinVar RCV003131487, Pathogenic
- E63* (p.Glu63Ter), NCI-TCGA Cosmic COSV5226, NCI-TCGA Cosmic COSV9929, cosmic curated COSV99293, Variant assessed as somatic; high impact.
- D67E (p.Asp67Glu), ExAC rs768773486, TOPMed rs768773486, gnomAD rs768773486, REVEL 0.47, CADD 0.62, Likely benign
- D67H (p.Asp67His), ExAC rs762102370, gnomAD rs762102370, REVEL 0.53, CADD 26.00
- D67Y (p.Asp67Tyr), ExAC rs762102370, gnomAD rs762102370
- E68* (p.Glu68Ter), rs13306787, ClinGen CA399796500, ClinVar RCV000756656, 1000Genomes rs13306787, CADD 34.00, Pathogenic
- E68K (p.Glu68Lys), rs13306787, ClinGen CA8600670, cosmic curated COSV52262, ClinVar RCV000288475, REVEL 0.08, CADD 16.40, Conflicting interpretations, not provided; Hereditary spherocytosis type 4; Autosomal dominant distal renal t
- K69N (p.Lys69Asn), gnomAD rs267604902, REVEL 0.23, CADD 19.60
- K69R (p.Lys69Arg), gnomAD rs1410054223, REVEL 0.14, CADD 10.80
- N70H (p.Asn70His), gnomAD rs2047437149, REVEL 0.27, CADD 22.70
- Q71K (p.Gln71Lys), Ensembl rs2047437121
- E72A (p.Glu72Ala), ExAC rs770137241, gnomAD rs770137241, REVEL 0.55, CADD 25.70
- E72D (p.Glu72Asp), rs13306788, ClinGen CA8600667, ClinVar RCV000294205, ClinVar RCV000346820, REVEL 0.37, CADD 9.48, Benign/Likely benign, Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; BLOOD GROUP, WALDNER
- E72K (p.Glu72Lys), ExAC rs780200225, gnomAD rs780200225, REVEL 0.62, CADD 23.90
- L73M (p.Leu73Met), rs781490287, ClinGen CA8600666, ClinVar RCV003491513, ClinVar RCV005022003, REVEL 0.46, CADD 11.00, Uncertain significance, Hereditary spherocytosis type 4; BLOOD GROUP--FROESE; BLOOD GROUP, WALDNER
- W75C (p.Trp75Cys), TOPMed rs2047436874, Uncertain significance, Inborn genetic diseases
- W75G (p.Trp75Gly), ExAC rs757668165, TOPMed rs757668165, gnomAD rs757668165, Uncertain significance
- W75R (p.Trp75Arg), rs757668165, ClinGen CA8600665, ClinVar RCV002797157, ExAC rs757668165, REVEL 0.93, CADD 28.10, Uncertain significance, not provided
- M76I (p.Met76Ile), ExAC rs778603628, TOPMed rs778603628, gnomAD rs778603628, REVEL 0.29, CADD 21.60
- M76L (p.Met76Leu), ExAC rs752316872, TOPMed rs752316872, gnomAD rs752316872, REVEL 0.18, CADD 17.60
- M76V (p.Met76Val), ExAC rs752316872, TOPMed rs752316872, gnomAD rs752316872, REVEL 0.15, CADD 17.50
- E77K (p.Glu77Lys), rs1567834917, ClinGen CA399796322, ClinVar RCV000722657, TOPMed rs1567834917, REVEL 0.86, CADD 26.00, Uncertain significance, not provided
- A78V (p.Ala78Val), rs186542577, ClinGen CA8600662, cosmic curated COSV52258, ClinVar RCV001507389, REVEL 0.19, CADD 8.09, Uncertain significance, not provided
- A79E (p.Ala79Glu), ESP rs376688172, ExAC rs376688172, TOPMed rs376688172, gnomAD rs376688172, REVEL 0.63, CADD 21.70
- A79G (p.Ala79Gly), ESP rs376688172, ExAC rs376688172, TOPMed rs376688172, gnomAD rs376688172, REVEL 0.61, CADD 17.20
- A79V (p.Ala79Val), cosmic curated COSV52258, ESP rs376688172, ExAC rs376688172, TOPMed rs376688172, REVEL 0.56, CADD 22.30, Uncertain significance, Inborn genetic diseases
- R80C (p.Arg80Cys), TOPMed rs199535281, gnomAD rs199535281, REVEL 0.61, CADD 27.10
- R80H (p.Arg80His), rs372860708, ClinGen CA8600657, NCI-TCGA Cosmic COSV5225, cosmic curated COSV52258, REVEL 0.41, CADD 11.40, Uncertain significance, not provided
- R80L (p.Arg80Leu), ExAC rs372860708, TOPMed rs372860708, gnomAD rs372860708, REVEL 0.52, CADD 16.50, Uncertain significance
- R80P (p.Arg80Pro), ExAC rs372860708, TOPMed rs372860708, gnomAD rs372860708, REVEL 0.60, CADD 17.10, Uncertain significance, Inborn genetic diseases; Hereditary spherocytosis type 4; BLOOD GROUP--SWANN SYS
- W81* (p.Trp81Ter), rs1598302037, ClinGen CA399796273, ClinVar RCV001002044, Ensembl rs1598302037, CADD 38.00, Pathogenic
- W81R (p.Trp81Arg), TOPMed rs1487738715, gnomAD rs1487738715, REVEL 0.94, CADD 28.20, Uncertain significance, Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal
- V82M (p.Val82Met), gnomAD rs1481733360, REVEL 0.35, CADD 13.30
- Q83R (p.Gln83Arg), Ensembl rs2144620969
- E86K (p.Glu86Lys), cosmic curated COSV52262, TOPMed rs1222201466
- N87K (p.Asn87Lys), rs761763084, ClinGen CA399796191, ClinVar RCV001124760, ClinVar RCV001125745, REVEL 0.42, CADD 24.00, Uncertain significance, Hereditary spherocytosis type 4; Autosomal dominant distal renal tubular acidosi
- L88V (p.Leu88Val), gnomAD rs1457516456, REVEL 0.19, CADD 8.06
- G89V (p.Gly89Val), NCI-TCGA Cosmic COSV9929, cosmic curated COSV99292, REVEL 0.43, CADD 22.30, Variant assessed as somatic; moderate impact.
- E90D (p.Glu90Asp), NCI-TCGA Cosmic COSV5226, cosmic curated COSV52261, Variant assessed as somatic; moderate impact., in SPH4
- E90K (p.Glu90Lys), rs28929480, ClinGen CA127402, NCI-TCGA Cosmic COSV5225, cosmic curated COSV52259, REVEL 0.38, CADD 8.24, Conflicting interpretations, Hereditary spherocytosis type 4; Cryohydrocytosis; Autosomal dominant distal ren
- G92V (p.Gly92Val), Ensembl rs2144620891
- A93S (p.Ala93Ser), rs145054469, ClinGen CA8600654, ClinVar RCV001507388, ClinVar RCV002567971, REVEL 0.04, CADD 0.85, Conflicting interpretations, not provided; Southeast Asian ovalocytosis; BLOOD GROUP--SWANN SYSTEM
- A93T (p.Ala93Thr), rs145054469, ClinGen CA399796122, ClinVar RCV003428297, Uncertain significance, not provided
- W94R (p.Trp94Arg), TOPMed rs2047436078, gnomAD rs2047436078, REVEL 0.86, CADD 27.40
- G95R (p.Gly95Arg), rs1380205574, ClinGen CA399796062, ClinVar RCV002047357, ClinVar RCV002506881, REVEL 0.82, CADD 24.50, Uncertain significance, not provided; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- G95S (p.Gly95Ser), gnomAD rs1380205574, REVEL 0.33, CADD 21.20, Uncertain significance
- R96C (p.Arg96Cys), rs538778224, ClinGen CA8600651, cosmic curated COSV10805, ClinVar RCV000275834, REVEL 0.34, CADD 25.00, Conflicting interpretations, Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; BLOOD GROUP, WALDNER
- R96H (p.Arg96His), rs141244582, ClinGen CA8600650, cosmic curated COSV52263, ClinVar RCV002678986, REVEL 0.11, CADD 19.00, Uncertain significance, Inborn genetic diseases; Cryohydrocytosis; Hereditary spherocytosis type 4
- R96P (p.Arg96Pro), 1000Genomes rs141244582, ESP rs141244582, ExAC rs141244582, TOPMed rs141244582, REVEL 0.20, CADD 15.90, Uncertain significance
- R96S (p.Arg96Ser), 1000Genomes rs538778224, ExAC rs538778224, TOPMed rs538778224, gnomAD rs538778224, REVEL 0.23, CADD 19.10, Likely benign
- P97L (p.Pro97Leu), TOPMed rs879167300, gnomAD rs879167300, REVEL 0.87, CADD 25.80, Uncertain significance, Hereditary spherocytosis type 4; BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP, WALDNER
- P97Q (p.Pro97Gln), cosmic curated COSV52259, TOPMed rs879167300, gnomAD rs879167300, Uncertain significance
- H98R (p.His98Arg), NCI-TCGA TCGA novel, REVEL 0.87, CADD 24.00, Variant assessed as somatic; moderate impact.
- H98Y (p.His98Tyr), ExAC rs771281363, gnomAD rs771281363, REVEL 0.79, CADD 25.90
- L99F (p.Leu99Phe), gnomAD rs1207640724, REVEL 0.39, CADD 23.90
- F104L (p.Phe104Leu), TOPMed rs2047435564, gnomAD rs2047435564, REVEL 0.42, CADD 24.40
- S106N (p.Ser106Asn), ExAC rs778203864, gnomAD rs778203864, REVEL 0.60, CADD 24.00
- L107F (p.Leu107Phe), rs2047435499, ClinGen CA399795791, ClinVar RCV001124757, ClinVar RCV001124758, Uncertain significance, Hereditary spherocytosis type 4; Autosomal dominant distal renal tubular acidosi
- L108P (p.Leu108Pro), ESP rs367688756, TOPMed rs367688756, REVEL 0.83, CADD 25.80
- E109D (p.Glu109Asp), ExAC rs753548782, TOPMed rs753548782, gnomAD rs753548782, REVEL 0.38, CADD 10.50
- E109G (p.Glu109Gly), gnomAD rs1321415255, REVEL 0.74, CADD 25.60
- E109K (p.Glu109Lys), rs1308401874, NCI-TCGA Cosmic COSV5226, cosmic curated COSV52261, gnomAD rs1308401874, REVEL 0.57, CADD 22.60, Variant assessed as somatic; moderate impact.
- R111C (p.Arg111Cys), rs13306774, ClinGen CA8600642, ClinVar RCV002291017, ClinVar RCV003101250, REVEL 0.56, CADD 26.30, Conflicting interpretations, not provided; Hereditary spherocytosis type 4
- R111G (p.Arg111Gly), ExAC rs13306774, TOPMed rs13306774, gnomAD rs13306774, REVEL 0.55, CADD 25.80, Uncertain significance, not provided
- R111H (p.Arg111His), ExAC rs767615788, TOPMed rs767615788, gnomAD rs767615788, REVEL 0.23, CADD 16.30
- R111P (p.Arg111Pro), ExAC rs767615788, TOPMed rs767615788, gnomAD rs767615788, REVEL 0.51, CADD 23.10, Uncertain significance, Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal
- R112K (p.Arg112Lys), Ensembl rs2047435198
- R112S (p.Arg112Ser), rs5037, UniProt VAR 014613, Ensembl rs5037
- V113D (p.Val113Asp), gnomAD rs1305089612, REVEL 0.44, CADD 23.10
- V113I (p.Val113Ile), rs142757938, ClinGen CA8600637, ClinVar RCV000883456, 1000Genomes rs142757938, REVEL 0.07, CADD 10.40, Conflicting interpretations, not provided
- T115I (p.Thr115Ile), rs2047435077, ClinGen CA399795615, ClinVar RCV001121982, ClinVar RCV001121983, Uncertain significance, Inborn genetic diseases; Hereditary spherocytosis type 4; Autosomal dominant dis
- K116=, NCI-TCGA TCGA novel, Variant assessed as somatic; low impact.
- G117C (p.Gly117Cys), gnomAD rs1417908221, REVEL 0.86, CADD 33.00
- G117D (p.Gly117Asp), ESP rs367854785, TOPMed rs367854785, gnomAD rs367854785, REVEL 0.88, CADD 29.60, Uncertain significance, Inborn genetic diseases
- T118A (p.Thr118Ala), gnomAD rs1441074553, REVEL 0.09, CADD 7.71
- L120F (p.Leu120Phe), NCI-TCGA Cosmic COSV9929, cosmic curated COSV99292, gnomAD rs2047433937, REVEL 0.58, CADD 25.70, Variant assessed as somatic; moderate impact.
- L120I (p.Leu120Ile), NCI-TCGA Cosmic COSV9929, Variant assessed as somatic; moderate impact.
- L121P (p.Leu121Pro), NCI-TCGA Cosmic COSV5226, cosmic curated COSV52262, REVEL 0.92, CADD 29.10, Variant assessed as somatic; moderate impact.
- L121V (p.Leu121Val), TOPMed rs1442706372, gnomAD rs1442706372, REVEL 0.55, CADD 23.50
- Q124* (p.Gln124Ter), rs1162787335, ClinGen CA399795348, ClinVar RCV002291016, Pathogenic
- Q124K (p.Gln124Lys), rs1162787335, ClinGen CA399795345, ClinVar RCV002836448, TOPMed rs1162787335, REVEL 0.29, CADD 9.47, Uncertain significance, Inborn genetic diseases
- Q124L (p.Gln124Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E125K (p.Glu125Lys), rs2509970759, ClinGen CA399795333, ClinVar RCV002898272, Uncertain significance, Inborn genetic diseases
- S127A (p.Ser127Ala), TOPMed rs1265248505, gnomAD rs1265248505, REVEL 0.31, CADD 19.30
- G130A (p.Gly130Ala), gnomAD rs1270796249, REVEL 0.33, CADD 14.90, Uncertain significance, not provided
- G130R (p.Gly130Arg), rs121912749, ClinGen CA127394, ClinVar RCV000019346, ClinVar RCV001121978, REVEL 0.53, CADD 22.80, Conflicting interpretations, Hereditary spherocytosis type 4; Cryohydrocytosis; Autosomal dominant distal ren
- V131A (p.Val131Ala), NCI-TCGA Cosmic COSV9929, cosmic curated COSV99293, Variant assessed as somatic; moderate impact.
- V131L (p.Val131Leu), rs766469709, ClinGen CA8600614, ClinVar RCV004461884, ClinVar RCV005006408, REVEL 0.25, CADD 20.50, Uncertain significance, Malaria, susceptibility to; Hereditary spherocytosis type 4; BLOOD GROUP--FROESE
- A132T (p.Ala132Thr), Ensembl rs2047433445, REVEL 0.42, CADD 20.00
- A132V (p.Ala132Val), gnomAD rs1453908890, REVEL 0.15, CADD 18.60
- N133D (p.Asn133Asp), Ensembl rs2047433361
- Q134E (p.Gln134Glu), ExAC rs772316375, gnomAD rs772316375, REVEL 0.08, CADD 10.20, Uncertain significance, Inborn genetic diseases
- Q134K (p.Gln134Lys), ExAC rs772316375, gnomAD rs772316375, REVEL 0.10, CADD 10.10
- L135V (p.Leu135Val), ExAC rs748601363, gnomAD rs748601363, REVEL 0.05, CADD 11.50
- L136I (p.Leu136Ile), NCI-TCGA Cosmic COSV9929, cosmic curated COSV99293, Variant assessed as somatic; moderate impact.
- D137E (p.Asp137Glu), Ensembl rs2047433220, REVEL 0.26, CADD 6.00
- D137G (p.Asp137Gly), ExAC rs774589011, gnomAD rs774589011, REVEL 0.80, CADD 28.20, Uncertain significance, Inborn genetic diseases
- D137N (p.Asp137Asn), gnomAD rs2047433269, REVEL 0.45, CADD 24.10
- R138G (p.Arg138Gly), TOPMed rs953305379, REVEL 0.09, CADD 8.64
- F139L (p.Phe139Leu), rs2509970651, ClinGen CA399794917, ClinVar RCV004461885, Uncertain significance, Inborn genetic diseases
- I140T (p.Ile140Thr), Ensembl rs2047433158
- F141L (p.Phe141Leu), rs1168035577, ClinGen CA399794889, ClinVar RCV003136792, ClinVar RCV005021823, REVEL 0.09, CADD 20.40, Uncertain significance, Hereditary spherocytosis type 4; BLOOD GROUP, WALDNER; Autosomal dominant distal
- D143A (p.Asp143Ala), ExAC rs745550262, TOPMed rs745550262, gnomAD rs745550262
- D143H (p.Asp143His), ExAC rs769500332, TOPMed rs769500332, gnomAD rs769500332
Public SLC4A1 analysis runs
- SLC4A1 analysis run — SLC4A1 (1,303 variants) — completed 2026-08-20